-
Sodium Intake of Canadians in 2017
In 2010, Canada's federal, provincial and territorial ministers of health agreed on the goal to reduce the average sodium intake of Canadians by a third, from 3400 mg to 2300 mg... -
Notice: ICH Guidance on Reporting Adverse Reactions to Marketed Health Products
Health Canada has implemented the International Council for Harmonisation of Technical Requirements of Pharmaceuticals for Human Use (ICH) Guidance: E2D Post-Approval Safety... -
Notice: Guidance Document – Requirements in the Recognition Process for...
This guidance document provides medical device stakeholders with information on the requirements that the Therapeutics Products Directorate will use in recognizing Auditing... -
Poly(amines) Group
These substances were identified for action under the Chemicals Management Plan (CMP). This screening assessment focuses on 9 substances referred to collectively as the... -
Notice - Prescription Drug List (PDL): Polymyxin B
The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will switch certain uses of Polymyxin B to prescription status for... -
Radiation Protection in Mammography: Recommended Safety Procedures for the...
Diagnostic X-ray imaging is an essential part of present day medical practice. However, mammographic X-ray procedures must be carefully managed, because X-radiation has the... -
Natural Health Product Licence Amendment and Notification Form User Guide
The Amendment and Notification Form (ANF) is the exclusive form to be used for submitting post licensing changes for a licensed natural health product (NHP) to the Natural and... -
Federal Contaminated Site Risk Assessment in Canada: Supplemental Guidance...
This guidance document was prepared to provide guidance for custodial departments. -
Draft guidance on improving indoor air quality in office buildings:...
The IAQ resolution process will often involve responding to a reported air quality issue. Occupants may report concerns through the supervisor or manager, the health and safety... -
Water Talk - Perfluoroalkylated substances in drinking water
Perfluoroalkylated substances (PFAS) are synthetic chemicals. Short-term exposure to PFAS in drinking water at levels slightly higher than the maximum acceptable concentrations... -
Proposed Registration Decision PRD2022-07, 98Sumithrin, MGK 3145 MUP, and...
This summary describes the key points of the evaluation, while the Science Evaluation of Proposed Registration Decision PRD2022-07, 98Sumithrin, MGK 3145 MUP, and MGK Formula... -
Health Product InfoWatch – February 2022
Provides clinically relevant safety information on pharmaceuticals, biologics, medical devices and natural health products for health care professionals. -
Importing, exporting or transhipping consumer products and cosmetics: Guide
This policy provides general information to any person – an individual or an organization that is involved in the import, export or transhipment of consumer products and... -
Submit questions or concerns about cannabis
You can submit questions and concerns about a cannabis site, product, service, accessory, promotion, or other aspects of laws and regulations regarding cannabis. Please review... -
Guidelines for Canadian Drinking Water Quality: Guideline Technical Document...
There is no evidence of adverse health effects specifically attributable to calcium in drinking water. Insufficient data are available to set a specific value for an aesthetic... -
Food Safety
Health Canada recognizes that a safe food supply is a major contributing factor to the health of Canadians. -
Airborne allergies
Explore airborne allergies, their causes and symptoms. Also find general tips for reducing your exposure to indoor allergens. -
Human Health Risk Assessment for Biodiesel Production, Distribution and Use in Canada
Health Canada assessed the potential human health implications of the widespread use of biodiesel in Canada, considering the production, distribution, storage and use stages in... -
Subsection 56(1) class exemption for patients, practitioners and pharmacists...
High-level description of when patients, practitioners and pharmacists are exempt from some sections of the Controlled Drugs and Substances Act during the COVID-19 (coronavirus)...
Vous pouvez également accéder à ce catalogue en utilisant l'API (cf. Documentation de l'API).